Lista de obras -

1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice

artículo científico publicado el 1 de noviembre de 1992

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

artículo científico publicado en 2020

Are newer insulin analogues better for people with Type 1 diabetes?

scientific article published on 21 January 2019

Benefit:Risk Profile of Dapagliflozin 5 mg in the DEPICT-1 and -2 Trials in Individuals with Type 1 Diabetes and BMI ≥27 kg/m2

artículo científico publicado en 2020

Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone ⬇️

artículo científico publicado el 1 de abril de 2003

Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans

artículo científico publicado en 2014

Early combination therapy delayed treatment escalation in newly-diagnosed young-onset type 2 diabetes - a sub-analysis of VERIFY study

artículo científico publicado en 2020

Effect of Once Weekly Dulaglutide by Baseline Beta-cell Function in People with Type 2 Diabetes in the AWARD Programme

artículo científico publicado en 2018

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Soc

artículo científico publicado en 2020

Hemodynamic and metabolic effects of the β-phosphorylated nitroxide 2-diethoxyphosphoryl-2,5,5-trimethylpyrrolidinoxyl during myocardial ischemia and reperfusion ⬇️

artículo científico publicado el 1 de mayo de 2003

Immune and cell therapy in type 1 diabetes: too little too late? ⬇️

artículo científico publicado el 15 de marzo de 2011

Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal-Bolus Insulin: Phase 4 OPTIMIZE Study

artículo científico publicado en 2020

Long-Term Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes: Pooled 52-Week Outcomes from the DEPICT-1 and -2 Studies

artículo científico publicado en 2020

Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial

scientific article published on 20 April 2020

Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation

artículo científico publicado en 2011

Positioning sulfonylureas in a modern treatment algorithm for patients with type 2 diabetes: expert opinion from a European Consensus Panel

artículo científico publicado en 2020

Prevention of Type I Diabetes in Nonobese Diabetic Mice by Late Intervention with Nonhypercalcemic Analogs of 1,25-Dihydroxyvitamin D3 in Combination with a Short Induction Course of Cyclosporin A* ⬇️

artículo científico publicado el 1 de enero de 1998

Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples

artículo científico publicado en 2021

Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: post hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin.

artículo científico publicado en 2018

Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes

scientific article published on 03 January 2019

Synergism between sirolimus and 1,25-dihydroxyvitamin D3 in vitro and in vivo ⬇️

artículo científico publicado el 1 de noviembre de 1997

The need for appropriate registration of pregnancy outcomes under newer oral glucose-lowering therapies

artículo científico publicado en 2018

Unraveling the effects of 1,25(OH)2D3 on global gene expression in pancreatic islets

article

Use of fast-acting insulin aspart in insulin pump therapy in clinical practice

artículo científico publicado en 2019

Lista de obras de

1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

Are newer insulin analogues better for people with Type 1 diabetes?

Benefit:Risk Profile of Dapagliflozin 5 mg in the DEPICT-1 and -2 Trials in Individuals with Type 1 Diabetes and BMI ≥27 kg/m2

Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone ⬇️

Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans

Early combination therapy delayed treatment escalation in newly-diagnosed young-onset type 2 diabetes - a sub-analysis of VERIFY study

Effect of Once Weekly Dulaglutide by Baseline Beta-cell Function in People with Type 2 Diabetes in the AWARD Programme

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Soc

Hemodynamic and metabolic effects of the β-phosphorylated nitroxide 2-diethoxyphosphoryl-2,5,5-trimethylpyrrolidinoxyl during myocardial ischemia and reperfusion ⬇️

Immune and cell therapy in type 1 diabetes: too little too late? ⬇️

Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal-Bolus Insulin: Phase 4 OPTIMIZE Study

Long-Term Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes: Pooled 52-Week Outcomes from the DEPICT-1 and -2 Studies

Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial

Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation

Positioning sulfonylureas in a modern treatment algorithm for patients with type 2 diabetes: expert opinion from a European Consensus Panel

Prevention of Type I Diabetes in Nonobese Diabetic Mice by Late Intervention with Nonhypercalcemic Analogs of 1,25-Dihydroxyvitamin D3 in Combination with a Short Induction Course of Cyclosporin A* ⬇️

Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples

Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: post hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin.

Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes

Synergism between sirolimus and 1,25-dihydroxyvitamin D3 in vitro and in vivo ⬇️

The need for appropriate registration of pregnancy outcomes under newer oral glucose-lowering therapies

Unraveling the effects of 1,25(OH)2D3 on global gene expression in pancreatic islets

Use of fast-acting insulin aspart in insulin pump therapy in clinical practice